Version 1
: Received: 12 June 2023 / Approved: 13 June 2023 / Online: 13 June 2023 (03:08:48 CEST)
How to cite:
Dharmalingam, K.; Ramasamy, K. Diabetic Retinopathy and the Extracellular Vesicles.. Preprints2023, 2023060865. https://doi.org/10.20944/preprints202306.0865.v1
Dharmalingam, K.; Ramasamy, K. Diabetic Retinopathy and the Extracellular Vesicles.. Preprints 2023, 2023060865. https://doi.org/10.20944/preprints202306.0865.v1
Dharmalingam, K.; Ramasamy, K. Diabetic Retinopathy and the Extracellular Vesicles.. Preprints2023, 2023060865. https://doi.org/10.20944/preprints202306.0865.v1
APA Style
Dharmalingam, K., & Ramasamy, K. (2023). Diabetic Retinopathy and the Extracellular Vesicles.. Preprints. https://doi.org/10.20944/preprints202306.0865.v1
Chicago/Turabian Style
Dharmalingam, K. and Kim Ramasamy. 2023 "Diabetic Retinopathy and the Extracellular Vesicles." Preprints. https://doi.org/10.20944/preprints202306.0865.v1
Abstract
Diabetes and diabetes-induced micro and macrovascular complications are major causes of healthcare problems. The extracellular vesicles are produced by all cells from all organisms. They are shown to have properties of the producer cells and also reflect the host physiology and pathology. Since the EVs represent the cellular state they are excellent biomarkers. In this review, we will focus on the EVs produced by the Neuro Vascular Unit cells of the eye as well as the extraocular cells in the onset and progression of diabetic retinopathy. A brief account of the use of these nanovesicles in personalised medicine is also given.
Keywords
Diabtetic retinoapthy; Exosomes; extracellular vesicles; precision medicine
Subject
Biology and Life Sciences, Cell and Developmental Biology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.